Report: 100 to 200 Congressional Reps and Staff Were Treated with Ivermectin Protocol From Front Line COVID Critical Care Doctors

This is beyond disturbing.  According to Dr Pierre Kory, MD, MPA, and verified by the Front Line COVID-19 Critical Care Alliance (FLCCC), 100 to 200 congressional reps and/or staff and families who contracted COVID-19 were treated with the Front Line Ivermectin protocol. [LINK and LINK]

This successful treatment is happening at the same time many congressional representatives are playing politics in favor of the vaccine; downplaying the effective anti-viral treatment and therapeutic approach with Ivermectin; and taking action to block regular American citizens from seeking similar treatment with Ivermectin.

Congress can seek treatment with a medication they simultaneously deny to others?  This is well beyond a “scandal”, and needs to be investigated quickly.

Additionally, as Merck has announced a new and similar anti-viral drug called Molnupiravir, two trial studies in India have requested to exit the trials.  Apparently the issue surrounds the new drug providing no benefit once a patient is moderately ill and hospitalized (READ MORE, Reuters Link).

Dr. John Campbell highlights a comparison between Ivermectin and Molnupiravir below: